 |
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Immune system
|
PDB id
|
|
|
|
1dqy
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
|
 |
|
 |
|
|
Gene Ontology (GO) functional annotation
|
|
|
|
 |
 |
 |
|
 |
 |
 |
 |
|
 |
|
Cellular component
|
extracellular region
|
2 terms
|
 |
|
Biological process
|
mycolate cell wall layer assembly
|
4 terms
|
 |
|
Biochemical function
|
transferase activity
|
3 terms
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Nat Struct Biol
7:141-146
(2000)
|
|
PubMed id:
|
|
|
|
|
| |
|
Crystal structure of the secreted form of antigen 85C reveals potential targets for mycobacterial drugs and vaccines.
|
|
D.R.Ronning,
T.Klabunde,
G.S.Besra,
V.D.Vissa,
J.T.Belisle,
J.C.Sacchettini.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The antigen 85 (ag85) complex, composed of three proteins (ag85A, B and C), is a
major protein component of the Mycobacterium tuberculosis cell wall. Each
protein possesses a mycolyltransferase activity required for the biogenesis of
trehalose dimycolate (cord factor), a dominant structure necessary for
maintaining cell wall integrity. The crystal structure of recombinant ag85C from
M. tuberculosis, refined to a resolution of 1.5 A, reveals an
alpha/beta-hydrolase polypeptide fold, and a catalytic triad formed by Ser 124,
Glu 228 and His 260. ag85C complexed with a covalent inhibitor implicates
residues Leu 40 and Met 125 as components of the oxyanion hole. A hydrophobic
pocket and tunnel extending 21 A into the core of the protein indicates the
location of a probable trehalose monomycolate binding site. Also, a large region
of conserved surface residues among ag85A, B and C is a probable site for the
interaction of ag85 proteins with human fibronectin.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 1.
Figure 1. Structure of C chain
of the secreted form of antigen 85C. a, Stereo diagram
showing the C trace
of apo-ag85C (residues 3 -282). b, Ribbon diagram of the C backbone
of ag85. Residues of the catalytic triad Ser 124, His 260, Glu
228 are shown (carbon atoms are shown in white, oxygen atoms are
red and nitrogen atoms are blue). The N and C termini of the
resolved structure are labeled N and C, respectively. The figure
was prepared with Setor40 c, 2F[o] - F[c] omit map of residues
122 -127 and DEP contoured at 1.5 .
Carbon atoms are shown in white, oxygen atoms in red, nitrogen
atoms in blue, phosphorus atom in orange and sulfur atom in
yellow. Figure was made using Swiss PDB Viewer41 and rendered
with POV-Ray42.
|
 |
Figure 3.
Figure 3. Schematic representation of the catalytic mechanism of
mycolyl transfer. In a three-step reaction, a mycolic acid,
shown in red, is transferred from the 6-OH of one molecule of
TMM to the 6'-OH of another TMM molecule, forming trehalose and
TDM. Protein side chains are shown in black. The carbohydrate
moiety of the substrate is in blue. The mycolic acid moiety is
represented by a red or green R.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from Macmillan Publishers Ltd:
Nat Struct Biol
(2000,
7,
141-146)
copyright 2000.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
B.Henderson,
S.Nair,
J.Pallas,
and
M.A.Williams
(2011).
Fibronectin: a multidomain host adhesin targeted by bacterial fibronectin-binding proteins.
|
| |
FEMS Microbiol Rev, 35,
147-200.
|
 |
|
|
|
|
 |
K.M.Backus,
H.I.Boshoff,
C.S.Barry,
O.Boutureira,
M.K.Patel,
F.D'Hooge,
S.S.Lee,
L.E.Via,
K.Tahlan,
C.E.Barry,
and
B.G.Davis
(2011).
Uptake of unnatural trehalose analogs as a reporter for Mycobacterium tuberculosis.
|
| |
Nat Chem Biol, 7,
228-235.
|
 |
|
|
|
|
 |
Y.Jiang,
K.L.Morley,
J.D.Schrag,
and
R.J.Kazlauskas
(2011).
Different active-site loop orientation in serine hydrolases versus acyltransferases.
|
| |
Chembiochem, 12,
768-776.
|
 |
|
|
|
|
 |
G.Singh,
G.Singh,
D.Jadeja,
and
J.Kaur
(2010).
Lipid hydrolizing enzymes in virulence: Mycobacterium tuberculosis as a model system.
|
| |
Crit Rev Microbiol, 36,
259-269.
|
 |
|
|
|
|
 |
R.Bou Raad,
X.Méniche,
C.de Sousa-d'Auria,
M.Chami,
C.Salmeron,
M.Tropis,
C.Labarre,
M.Daffé,
C.Houssin,
and
N.Bayan
(2010).
A deficiency in arabinogalactan biosynthesis affects Corynebacterium glutamicum mycolate outer membrane stability.
|
| |
J Bacteriol, 192,
2691-2700.
|
 |
|
|
|
|
 |
R.Kalscheuer,
B.Weinrick,
U.Veeraraghavan,
G.S.Besra,
and
W.R.Jacobs
(2010).
Trehalose-recycling ABC transporter LpqY-SugA-SugB-SugC is essential for virulence of Mycobacterium tuberculosis.
|
| |
Proc Natl Acad Sci U S A, 107,
21761-21766.
|
 |
|
|
|
|
 |
X.Bai,
and
R.Borrow
(2010).
Genetic shifts of Neisseria meningitidis serogroup B antigens and the quest for a broadly cross-protective vaccine.
|
| |
Expert Rev Vaccines, 9,
1203-1217.
|
 |
|
|
|
|
 |
A.K.Sanki,
J.Boucau,
D.R.Ronning,
and
S.J.Sucheck
(2009).
Antigen 85C-mediated acyl-transfer between synthetic acyl donors and fragments of the arabinan.
|
| |
Glycoconj J, 26,
589-596.
|
 |
|
|
|
|
 |
A.K.Sanki,
J.Boucau,
F.E.Umesiri,
D.R.Ronning,
and
S.J.Sucheck
(2009).
Design, synthesis and biological evaluation of sugar-derived esters, alpha-ketoesters and alpha-ketoamides as inhibitors for Mycobacterium tuberculosis antigen 85C.
|
| |
Mol Biosyst, 5,
945-956.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
P.K.Rao,
and
Q.Li
(2009).
Principal Component Analysis of Proteome Dynamics in Iron-starved Mycobacterium Tuberculosis.
|
| |
J Proteomics Bioinform, 2,
19-31.
|
 |
|
|
|
|
 |
A.Tanghe,
J.P.Dangy,
G.Pluschke,
and
K.Huygen
(2008).
Improved Protective Efficacy of a Species-Specific DNA Vaccine Encoding Mycolyl-Transferase Ag85A from Mycobacterium ulcerans by Homologous Protein Boosting.
|
| |
PLoS Negl Trop Dis, 2,
e199.
|
 |
|
|
|
|
 |
C.H.Lu,
S.W.Huang,
Y.L.Lai,
C.P.Lin,
C.H.Shih,
C.C.Huang,
W.L.Hsu,
and
J.K.Hwang
(2008).
On the relationship between the protein structure and protein dynamics.
|
| |
Proteins, 72,
625-634.
|
 |
|
|
|
|
 |
M.H.Kim,
B.S.Kang,
S.Kim,
K.J.Kim,
C.H.Lee,
B.C.Oh,
S.C.Park,
and
T.K.Oh
(2008).
The crystal structure of the estA protein, a virulence factor from Streptococcus pneumoniae.
|
| |
Proteins, 70,
578-583.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
B.Al-Sayyed,
S.Piperdi,
X.Yuan,
A.Li,
G.S.Besra,
W.R.Jacobs,
A.Casadevall,
and
A.Glatman-Freedman
(2007).
Monoclonal antibodies to Mycobacterium tuberculosis CDC 1551 reveal subcellular localization of MPT51.
|
| |
Tuberculosis (Edinb), 87,
489-497.
|
 |
|
|
|
|
 |
M.K.Annamala,
K.K.Inampudi,
and
L.Guruprasad
(2007).
Docking of phosphonate and trehalose analog inhibitors into M. tuberculosis mycolyltransferase Ag85C: Comparison of the two scoring fitness functions GoldScore and ChemScore, in the GOLD software.
|
| |
Bioinformation, 1,
339-350.
|
 |
|
|
|
|
 |
T.Katsube,
S.Matsumoto,
M.Takatsuka,
M.Okuyama,
Y.Ozeki,
M.Naito,
Y.Nishiuchi,
N.Fujiwara,
M.Yoshimura,
T.Tsuboi,
M.Torii,
N.Oshitani,
T.Arakawa,
and
K.Kobayashi
(2007).
Control of cell wall assembly by a histone-like protein in Mycobacteria.
|
| |
J Bacteriol, 189,
8241-8249.
|
 |
|
|
|
|
 |
A.G.Kinhikar,
D.Vargas,
H.Li,
S.B.Mahaffey,
L.Hinds,
J.T.Belisle,
and
S.Laal
(2006).
Mycobacterium tuberculosis malate synthase is a laminin-binding adhesin.
|
| |
Mol Microbiol, 60,
999.
|
 |
|
|
|
|
 |
H.G.Ramulu,
S.Adindla,
and
L.Guruprasad
(2006).
Analysis and modeling of mycolyl-transferases in the CMN group.
|
| |
Bioinformation, 1,
161-169.
|
 |
|
|
|
|
 |
M.Romano,
V.Roupie,
X.M.Wang,
O.Denis,
F.Jurion,
P.Y.Adnet,
R.Laali,
and
K.Huygen
(2006).
Immunogenicity and protective efficacy of tuberculosis DNA vaccines combining mycolyl-transferase Ag85A and phosphate transport receptor PstS-3.
|
| |
Immunology, 118,
321-332.
|
 |
|
|
|
|
 |
V.L.Arcus,
J.S.Lott,
J.M.Johnston,
and
E.N.Baker
(2006).
The potential impact of structural genomics on tuberculosis drug discovery.
|
| |
Drug Discov Today, 11,
28-34.
|
 |
|
|
|
|
 |
B.C.VanderVen,
J.D.Harder,
D.C.Crick,
and
J.T.Belisle
(2005).
Export-mediated assembly of mycobacterial glycoproteins parallels eukaryotic pathways.
|
| |
Science, 309,
941-943.
|
 |
|
|
|
|
 |
K.Takayama,
C.Wang,
and
G.S.Besra
(2005).
Pathway to synthesis and processing of mycolic acids in Mycobacterium tuberculosis.
|
| |
Clin Microbiol Rev, 18,
81.
|
 |
|
|
|
|
 |
L.Nguyen,
S.Chinnapapagari,
and
C.J.Thompson
(2005).
FbpA-Dependent biosynthesis of trehalose dimycolate is required for the intrinsic multidrug resistance, cell wall structure, and colonial morphology of Mycobacterium smegmatis.
|
| |
J Bacteriol, 187,
6603-6611.
|
 |
|
|
|
|
 |
S.Sasso,
C.Ramakrishnan,
M.Gamper,
D.Hilvert,
and
P.Kast
(2005).
Characterization of the secreted chorismate mutase from the pathogen Mycobacterium tuberculosis.
|
| |
FEBS J, 272,
375-389.
|
 |
|
|
|
|
 |
D.R.Ronning,
V.Vissa,
G.S.Besra,
J.T.Belisle,
and
J.C.Sacchettini
(2004).
Mycobacterium tuberculosis antigen 85A and 85C structures confirm binding orientation and conserved substrate specificity.
|
| |
J Biol Chem, 279,
36771-36777.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
F.Vincent,
D.Yates,
E.Garman,
G.J.Davies,
and
J.A.Brannigan
(2004).
The three-dimensional structure of the N-acetylglucosamine-6-phosphate deacetylase, NagA, from Bacillus subtilis: a member of the urease superfamily.
|
| |
J Biol Chem, 279,
2809-2816.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
H.Cai,
X.Tian,
X.D.Hu,
Y.H.Zhuang,
and
Y.X.Zhu
(2004).
Combined DNA vaccines formulated in DDA enhance protective immunity against tuberculosis.
|
| |
DNA Cell Biol, 23,
450-456.
|
 |
|
|
|
|
 |
J.D.Mougous,
C.J.Petzold,
R.H.Senaratne,
D.H.Lee,
D.L.Akey,
F.L.Lin,
S.E.Munchel,
M.R.Pratt,
L.W.Riley,
J.A.Leary,
J.M.Berger,
and
C.R.Bertozzi
(2004).
Identification, function and structure of the mycobacterial sulfotransferase that initiates sulfolipid-1 biosynthesis.
|
| |
Nat Struct Mol Biol, 11,
721-729.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
L.G.Dover,
A.M.Cerdeño-Tárraga,
M.J.Pallen,
J.Parkhill,
and
G.S.Besra
(2004).
Comparative cell wall core biosynthesis in the mycolated pathogens, Mycobacterium tuberculosis and Corynebacterium diphtheriae.
|
| |
FEMS Microbiol Rev, 28,
225-250.
|
 |
|
|
|
|
 |
L.Shi,
R.North,
and
M.L.Gennaro
(2004).
Effect of growth state on transcription levels of genes encoding major secreted antigens of Mycobacterium tuberculosis in the mouse lung.
|
| |
Infect Immun, 72,
2420-2424.
|
 |
|
|
|
|
 |
M.Suzuki,
T.Aoshi,
T.Nagata,
and
Y.Koide
(2004).
Identification of murine H2-Dd- and H2-Ab-restricted T-cell epitopes on a novel protective antigen, MPT51, of Mycobacterium tuberculosis.
|
| |
Infect Immun, 72,
3829-3837.
|
 |
|
|
|
|
 |
R.Sun,
P.J.Converse,
C.Ko,
S.Tyagi,
N.E.Morrison,
and
W.R.Bishai
(2004).
Mycobacterium tuberculosis ECF sigma factor sigC is required for lethality in mice and for the conditional expression of a defined gene set.
|
| |
Mol Microbiol, 52,
25-38.
|
 |
|
|
|
|
 |
S.Canaan,
D.Maurin,
H.Chahinian,
B.Pouilly,
C.Durousseau,
F.Frassinetti,
L.Scappuccini-Calvo,
C.Cambillau,
and
Y.Bourne
(2004).
Expression and characterization of the protein Rv1399c from Mycobacterium tuberculosis. A novel carboxyl esterase structurally related to the HSL family.
|
| |
Eur J Biochem, 271,
3953-3961.
|
 |
|
|
|
|
 |
C.V.Smith,
and
J.C.Sacchettini
(2003).
Mycobacterium tuberculosis: a model system for structural genomics.
|
| |
Curr Opin Struct Biol, 13,
658-664.
|
 |
|
|
|
|
 |
M.Bellinzoni,
and
G.Riccardi
(2003).
Techniques and applications: The heterologous expression of Mycobacterium tuberculosis genes is an uphill road.
|
| |
Trends Microbiol, 11,
351-358.
|
 |
|
|
|
|
 |
S.K.Singh,
M.M.Babu,
and
P.Balaram
(2003).
Registering alpha-helices and beta-strands using backbone C-H...O interactions.
|
| |
Proteins, 51,
167-171.
|
 |
|
|
|
|
 |
C.W.Goulding,
A.Parseghian,
M.R.Sawaya,
D.Cascio,
M.I.Apostol,
M.L.Gennaro,
and
D.Eisenberg
(2002).
Crystal structure of a major secreted protein of Mycobacterium tuberculosis-MPT63 at 1.5-A resolution.
|
| |
Protein Sci, 11,
2887-2893.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
G.Harth,
M.A.Horwitz,
D.Tabatadze,
and
P.C.Zamecnik
(2002).
Targeting the Mycobacterium tuberculosis 30/32-kDa mycolyl transferase complex as a therapeutic strategy against tuberculosis: Proof of principle by using antisense technology.
|
| |
Proc Natl Acad Sci U S A, 99,
15614-15619.
|
 |
|
|
|
|
 |
J.G.Leid,
D.Hunter,
and
C.A.Speer
(2002).
Early diagnosis of Johne's disease in the American bison by monoclonal antibodies directed against antigen 85.
|
| |
Ann N Y Acad Sci, 969,
66-72.
|
 |
|
|
|
|
 |
S.D'Souza,
V.Rosseels,
O.Denis,
A.Tanghe,
N.De Smet,
F.Jurion,
K.Palfliet,
N.Castiglioni,
A.Vanonckelen,
C.Wheeler,
and
K.Huygen
(2002).
Improved tuberculosis DNA vaccines by formulation in cationic lipids.
|
| |
Infect Immun, 70,
3681-3688.
|
 |
|
|
|
|
 |
V.Puech,
C.Guilhot,
E.Perez,
M.Tropis,
L.Y.Armitige,
B.Gicquel,
and
M.Daffé
(2002).
Evidence for a partial redundancy of the fibronectin-binding proteins for the transfer of mycoloyl residues onto the cell wall arabinogalactan termini of Mycobacterium tuberculosis.
|
| |
Mol Microbiol, 44,
1109-1122.
|
 |
|
|
|
|
 |
A.Tanghe,
J.Content,
J.P.Van Vooren,
F.Portaels,
and
K.Huygen
(2001).
Protective efficacy of a DNA vaccine encoding antigen 85A from Mycobacterium bovis BCG against Buruli ulcer.
|
| |
Infect Immun, 69,
5403-5411.
|
 |
|
|
|
|
 |
A.Tanghe,
S.D'Souza,
V.Rosseels,
O.Denis,
T.H.Ottenhoff,
W.Dalemans,
C.Wheeler,
and
K.Huygen
(2001).
Improved immunogenicity and protective efficacy of a tuberculosis DNA vaccine encoding Ag85 by protein boosting.
|
| |
Infect Immun, 69,
3041-3047.
|
 |
|
|
|
|
 |
T.E.Secott,
T.L.Lin,
and
C.C.Wu
(2001).
Fibronectin attachment protein homologue mediates fibronectin binding by Mycobacterium avium subsp. paratuberculosis.
|
| |
Infect Immun, 69,
2075-2082.
|
 |
|
|
|
|
 |
M.Daffé
(2000).
The mycobacterial antigens 85 complex - from structure to function and beyond.
|
| |
Trends Microbiol, 8,
438-440.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
|